Assessment of durable responses after brexucabtagene autoleucel (brexu-cel) in relapsed/refractory mantle cell lymphoma (R/R MCL)

被引：0
|
作者：
Pindoria, Lohit
Munoz, Javier [2 ]
Reagan, Patrick [3 ]
Goy, Andre [4 ]
Miklos, David [5 ]
Zheng, Dan [1 ]
Fang, Xiang [1 ]
Shen, Rhine [1 ]
Siddiqi, Rubina [1 ]
Kloos, Ioana [1 ]
Kersten, Marie Jose [6 ]
Wang, Michael [7 ]
机构：
[1] Kite, Santa Monica, CA USA
[2] Banner MD Anderson Canc Ctr, Gilbert, AZ USA
[3] Univ Rochester, Sch Med, Rochester, NY USA
[4] John Theurer Canc Ctr, Hackensack, NJ USA
[5] Stanford Univ, Sch Med, Stanford, CA USA
[6] Univ Amsterdam, Amsterdam UMC, HOVON LLPC, Amsterdam, Netherlands
[7] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2023年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH23-PO88
引用
收藏
页码：113 / 114
页数：2
相关论文
共 50 条
  • [21] Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
    Iacoboni, Gloria
    Rejeski, Kai
    Villacampa, Guillermo
    van Doesum, Jaap A.
    Chiappella, Annalisa
    Bonifazi, Francesca
    Lopez-Corral, Lucia
    van Aalderen, Michiel
    Kwon, Mi
    Martinez-Cibrian, Nuria
    Bramanti, Stefania
    Luis Reguera-Ortega, Juan
    Camacho-Arteaga, Lina
    Schmidt, Christian
    Marin-Niebla, Ana
    Jose Kersten, Marie
    Martin Garcia-Sancho, Alejandro
    Zinzani, Pier Luigi
    Corradini, Paolo
    van Meerten, Tom
    Subklewe, Marion
    Barba, Pere
    BLOOD ADVANCES, 2022, 6 (12) : 3606 - 3610
  • [22] Real-World Evidence of Brexucabtagene Autoleucel for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
    Iacoboni, Gloria
    Rejeski, Kai
    Camacho, Lina
    Chiappella, Annalisa
    Guadagnuolo, Serafina
    Lopez Corral, Lucia
    Bastos-Oreiro, Mariana
    Delgado Serrano, Javier
    Schmidt, Christian
    Carpio, Cecilia
    Luis Reguera, Juan
    Kwon, Mi
    Martin Garcia-Sancho, Alejandro
    Luigi Zinzani, Pier
    Corradini, Paolo
    Subklewe, Marion
    Barba, Pere
    BLOOD, 2021, 138
  • [23] Cost-effectiveness studies of brexu-cel for relapsed/refractory B-cell acute lymphoblastic leukemia and mantle cell lymphoma: a systematic review
    Khatiwada, Asmita Priyadarshini
    Kamel, Ahmed Mostafa Ahmed
    Chaiyakunapruk, Nathorn
    Ngorsuraches, Surachat
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2025, 25 (03) : 323 - 335
  • [24] Impact of age, prior therapies, and subsequent transplant on long-term outcomes of adults with relapsed or refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) treated with brexucabtagene autoleucel (brexu-cel) in ZUMA-3.
    Shah, Bijal D.
    Cassaday, Ryan Daniel
    Park, Jae H.
    Houot, Roch
    Oluwole, Olalekan O.
    Logan, Aaron
    Boissel, Nicolas
    Leguay, Thibaut
    Bishop, Michael Russell
    Topp, Max S.
    O'Dwyer, Kristen M.
    Baer, Maria R.
    Schiller, Gary J.
    Abedi, Mehrdad
    Minnema, Monique C.
    Stiff, Patrick J.
    Zhou, Lang
    Hadjivassileva, Tsveta
    Khalid, Rita Damico
    Ghobadi, Armin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [25] Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma: Real-World Outcomes in the United Kingdom
    O'Reilly, Maeve A.
    Sanderson, Robin
    Wilson, William
    Burns, David
    Besley, Caroline
    Creasey, Thomas
    Uttenthal, Ben
    Elliot, Johnathon
    Roddie, Claire
    Kuhnl, Andrea
    Paneesha, Shankara
    Seymour, Frances
    Iyengar, Sunil
    Rubio, Lourdes
    Wilson, Matthew
    Boyle, Stephen
    Cheok, Kathleen Pl
    Collins, Graham P.
    Johnson, Rod
    McMillan, Andrew K.
    BLOOD, 2022, 140 : 7519 - 7521
  • [26] EXPOSURE RESPONSE (E-R) RELATIONSHIPS OF LISOCABTAGENE MARALEUCEL (LISO-CEL) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL)
    Balasubramanian, N.
    Cummings, J.
    Lin, H.
    Raviele, A.
    Peng, L.
    Omidpanah, A.
    Espinola, R.
    Kostic, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S54 - S54
  • [27] Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory (R/R) mantle cell lymphoma (MCL).
    Epperla, Narendranath
    Hamadani, Mehdi
    Ahn, Kwang Woo
    Oak, Eunhye
    Cashen, Amanda F.
    Kanate, Abraham Sebastian
    Calzada, Oscar
    Farmer, Zachary Luke
    Tallarico, Michael
    Nabhan, Chadi
    Costa, Luciano J.
    Kenkre, Vaishalee Padgaonkar
    Ghosh, Nilanjan
    Cohen, Jonathon Brett
    Hari, Parameswaran
    Fenske, Timothy S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [28] Safety and Efficacy of Relmacabtagene Autoleucel (relma-cel) in Adults with Relapsed/Refractory Mantle Cell Lymphoma (r/r MCL): Updated Results from a Phase II Open-Label Study in China
    Song, Yuqin
    Zhou, Keshu
    Li, Lanfang
    Liang, Aibin
    Qin, Yun
    Xia, Zhen
    Gu, Yongen
    Zhou, Zisong
    Tian, Alex
    Zhu, Jun
    BLOOD, 2023, 142
  • [29] Real-World (RW) Outcomes for Brexucabtagene Autoleucel (Brexu-Cel) Treatment in Patients (Pts) with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) By High-Risk Features and Prior Treatments: Updated Evidence from the CIBMTR® Registry
    Wudhikarn, Kitsada
    Bezerra, Evandro
    Yang, Yang
    Perales, Miguel-Angel
    Jain, Nitin
    Gergis, Usama
    Aribi, Ahmed
    Hill, Laquisa
    Leonard, Jessica T.
    Lutfi, Forat
    Kim, Soyoung
    Bye, Matthew
    Hu, Zhen-Huan
    Wang, Hai-Lin
    Luo, Zhong-Cheng
    Siddiqi, Rubina
    Khalid, Rita Damico
    Speiser, Jessica
    Pasquini, Marcelo C.
    Kebriaei, Partow
    Muffly, Lori
    BLOOD, 2024, 144 : 5092 - 5093
  • [30] Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma: Real World Experience from the US Lymphoma CAR T Consortium
    Wang, Yucai
    Jain, Preetesh
    Locke, Frederick L.
    Munoz, Javier
    Maurer, Matthew J.
    Beitinjaneh, Amer
    Frank, Matthew J.
    Dahiya, Saurabh
    McGuirk, Joseph P.
    Jacobs, Miriam T.
    Goy, Andre H.
    Vose, Julie M.
    Hill, Brian T.
    Oluwole, Olalekan O.
    Deol, Abhinav
    Shah, Bijal D.
    Paludo, Jonas
    Wang, Trent
    Lekakis, Lazaros J.
    Miklos, David B.
    Rapoport, Aaron P.
    Ghobadi, Armin
    Neelapu, Sattva S.
    Lin, Yi
    Wang, Michael
    Jain, Michael D.
    BLOOD, 2021, 138
12345